Treatment with ICT significantly downregulated FABP5 expression, suggesting that ICT may suppress the malignant phenotype of HCC cells by disrupting lipid metabolic pathways mediated by FABP5. This evidence concerns the gene FABP5 and hepatocellular carcinoma.